A recent report published by Infinium Global Research on cardiac imaging software market provides in-depth analysis of segments and sub-segments in the global as well as regional cardiac imaging software market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional cardiac imaging software market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global cardiac imaging software market.
The cardiac imaging software market is experiencing rapid change, driven by the increasing prevalence of cardiovascular diseases, growing demand for non-invasive diagnostics, and the adoption of advanced technologies such as artificial intelligence (AI), 3D visualization, and cloud-based platforms. Cardiac imaging software, including modalities like computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, X-ray imaging, and SPECT, is transforming early diagnosis, treatment planning, and clinical decision-making through improved accuracy and automated image analysis. Additionally, innovations like AI-powered cardiac risk prediction, real-time image-guided procedures, and cloud-enabled telecardiology are enhancing patient care by boosting diagnostic precision and reducing turnaround times. Hospitals and diagnostic centers are increasingly adopting multi-modality imaging solutions that connect with electronic health records (EHR) to streamline workflows and improve patient outcomes.
The rising prevalence of cardiovascular diseases is driving the cardiac imaging software market as conditions such as coronary artery disease, heart failure, and arrhythmias demand accurate and timely diagnosis. Increasing cases linked to sedentary lifestyles, obesity, diabetes, and aging populations are boosting the need for advanced imaging solutions. Additionally, rising healthcare expenditure and infrastructure development are driving the cardiac imaging software market by improving access to advanced diagnostic technologies. Governments and private healthcare providers are increasing investments in modern hospitals, diagnostic centers, and digital health solutions to address the growing burden of cardiovascular diseases. These investments enable the adoption of high-end imaging modalities such as CT, MRI, and ultrasound, integrated with AI-powered software, enhancing diagnostic accuracy, patient outcomes, and overall efficiency of cardiac care services. However, the high implementation and maintenance costs may hamper the growth of the cardiac imaging software market, particularly in small hospitals and diagnostic centers with limited budgets. Advanced imaging platforms require expensive hardware, software licensing, regular upgrades, and skilled IT support, which increases the total cost of ownership. Furthermore, the shift toward personalized and preventive healthcare is creating opportunities for the cardiac imaging software market. As healthcare providers focus on early detection and tailored treatment plans, advanced imaging software plays a crucial role in delivering precise diagnostics and risk assessments.
The magnetic resonance segment is expected to lead the market throughout the forecast period. Magnetic Resonance Imaging (MRI) has become essential in cardiac imaging, as it provides high-resolution images of the heart's structure and function without using ionizing radiation. It is particularly useful for diagnosing complex conditions such as cardiomyopathies and congenital heart defects. Advanced cardiac MRI software enhances these capabilities by utilizing algorithms that automate measurements and improve diagnostic accuracy. Innovations such as real-time imaging and motion correction further enhance image quality and patient comfort. For example, the National Library of Medicine reports that nearly 40 million MRI scans are performed annually in the United States.
Based on application, the global cardiac imaging software market is divided into diagnostic imaging and image-guided treatment. Diagnostic imaging dominated the market during the forecasted period, primarily because it is crucial for the accurate detection, evaluation, and monitoring of various cardiac conditions. This segment plays a vital role in patient diagnosis and management. The focus of the diagnostic imaging segment is to enhance precision and efficiency by utilizing advanced technologies such as MRI, CT, and ultrasound, which are further integrated with AI and machine learning for automated analysis and improved diagnostics. Leading companies in this field, including Siemens Healthineers, Koninklijke Philips N.V., and GE Healthcare, are advancing the diagnostic imaging segment with platforms that offer detailed imaging, integrated modalities, and high-resolution diagnostics, thus promoting growth and innovation in cardiac care.
Based on the end user, the global cardiac imaging software market is divided into hospitals, diagnostic centers, and others. Hospitals are anticipated to dominate the market during the forecasted period, due to they serve as the primary centers for advanced diagnostic procedures and treatments. This necessitates the extensive use of advanced imaging technologies to manage various cardiac conditions. Hospitals play a critical role in the cardiac imaging software market by utilizing technologies such as MRI, CT, and echocardiography. These tools enhance diagnostic accuracy, improve patient outcomes, and streamline clinical workflows. Cardiac imaging software allows for non-invasive assessments, precise detection of cardiovascular diseases, and efficient treatment planning.
The North America region is expected to dominate the cardiac imaging software market during the forecast period. This dominance is attributed to the high prevalence of cardiovascular diseases, advanced healthcare infrastructure, and strong adoption of cutting-edge imaging technologies like AI-powered diagnostics and 3D/4D visualization tools. The presence of major market players, robust R&D investments, and favourable reimbursement policies further strengthen the region’s market position. Moreover, the Asia-Pacific region is expected to be the fastest-growing region in the cardiac imaging software market during the forecast period. The region's rapid growth is fuelled by a rising prevalence of cardiovascular diseases, increasing healthcare investments, and expanding diagnostic infrastructure in countries such as China, India, and Japan. Government initiatives to improve cardiac care, coupled with the adoption of advanced imaging modalities such as CT, MRI, and ultrasound, are boosting demand. Further, growing awareness of preventive healthcare, technological advancements, and the entry of global players are accelerating market expansion in the Asia-Pacific.
In January 2024, Siemens Healthineers announced FDA clearance for syngo Virtual Cockpit, a secure platform for real-time communication and collaboration on medical images among healthcare professionals at different locations. It connects to various imaging devices, including CT, MR, PET, SPECT, and hybrid scanners from Siemens and other vendors.
In March 2025, GE HealthCare introduced the Revolution™ Vibe CT system, featuring Unlimited One-Beat Cardiac imaging for high-quality images in challenging cases like atrial fibrillation. With ECG-less Cardiac, TrueFidelity DL, SnapShot Freeze 2, and AI-powered Effortless Workflow, Revolution Vibe enables quick diagnoses, enhances patient comfort, and improves workflow efficiency.
In February 2025, Koninklijke Philips N.V., a global leader in health technology, enhances its MRI leadership by launching SmartSpeed Precise, which is powered by dual AI engines. This next-generation solution builds on its award-winning Compressed SENSE and SmartSpeed technologies, offering faster scans with improved image quality.
| Report Coverage | Details |
|---|---|
| Market Size in 2023 | USD 620.00 Million |
| Market Size by 2032 | USD 1,344.60 Million |
| Growth Rate from 2024 to 2032 | CAGR of 9.00% |
| Largest Market | North America |
| No. of Pages | 255 |
| Market Drivers |
|
| Market Segmentation | By Imaging Modality, By Application, and By End User |
| Regional Scope | North America, Europe, Asia Pacific, and RoW |
The report on global cardiac imaging software market provides a detailed analysis of segments in the market based on Imaging Modality, Application, and End User.
· Computed Tomography
· Magnetic Resonance Imaging
· Ultrasound Imaging
· SPECT
· Others
· Diagnostic Imaging
· Image Guided Treatment
· Hospitals
· Diagnostic Centers
· Others
· Siemens Healthineers AG
· GE HealthCare
· CANON MEDICAL SYSTEMS CORPORATION
· FUJIFILM Holdings Corporation
· Circle Cardiovascular Imaging Inc.
· Koninklijke Philips N.V.
· NeoSoft, LLC
· Intelerad
· Pie Medical Imaging B.V.
· Medis Medical Imaging Systems B.V.
The report provides deep insights into demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the cardiac imaging software market. Moreover, the study highlights current market trends and provides forecasts from 2024-2032. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.